(UNMA) Unum - Ratings and Ratios
Exchange: NYSE • Country: USA • Currency: USD • Type: Common Stock • ISIN: US91529Y6014
UNMA: Disability Insurance, Life Insurance, Health Insurance
Unum Group (NYSE:UNMA), a leading provider of financial protection solutions, operates across the United States, the United Kingdom, and international markets through four key segments: Unum US, Unum UK, Colonial Life, and Closed Block. The companys extensive product portfolio includes group long-term and short-term disability insurance, group life insurance, accidental death and dismemberment coverage, as well as supplemental and voluntary products such as individual disability insurance, voluntary benefits, dental, and vision coverage. Additionally, Unum offers accident, sickness, and disability insurance, life insurance, cancer, and critical illness products. The company also provides group pension plans, individual life insurance, corporate-owned life insurance, reinsurance pools, and management operations.
Unum primarily markets its products to employers, designing them to benefit employees. The company employs a multi-channel distribution strategy, utilizing field sales personnel, independent brokers, consultants, and an independent contractor agency sales force. Founded in 1848 and headquartered in Chattanooga, Tennessee, Unum Group has established itself as a significant player in the life and health insurance industry, known for its comprehensive disability and life insurance solutions.
Looking ahead, the three-month forecast for Unum Group suggests stability with potential for slight volatility. From a technical standpoint, the stock price is currently hovering around its 20-day and 50-day Simple Moving Averages (SMA), indicating a possible period of consolidation. The low Average True Range (ATR) of 0.25 signals minimal price fluctuations, suggesting a relatively stable trading environment. On the fundamental side, Unums strong Return on Equity (RoE) of 16.23% and a low Price-to-Earnings (P/E) ratio of 5.07 underscore its attractive valuation and profitability. These factors, combined with a market capitalization of $5.523 billion, position Unum as a stable investment with potential for modest growth, supported by its robust financial health and established market presence.
Additional Sources for UNMA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UNMA Stock Overview
Market Cap in USD | 5,524m |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 2018-06-19 |
UNMA Stock Ratings
Growth Rating | 54.6 |
Fundamental | 78.1 |
Dividend Rating | 53.3 |
Rel. Strength | -13.3 |
Analysts | - |
Fair Price Momentum | 25.28 USD |
Fair Price DCF | - |
UNMA Dividends
Dividend Yield 12m | 6.40% |
Yield on Cost 5y | 8.86% |
Annual Growth 5y | 0.00% |
Payout Consistency | 96.9% |
UNMA Growth Ratios
Growth Correlation 3m | 30.7% |
Growth Correlation 12m | 45.5% |
Growth Correlation 5y | 75.4% |
CAGR 5y | 6.63% |
CAGR/Max DD 5y | 0.44 |
Sharpe Ratio 12m | -0.43 |
Alpha | -0.29 |
Beta | 0.133 |
Volatility | 12.75% |
Current Volume | 18k |
Average Volume 20d | 9k |
As of May 01, 2025, the stock is trading at USD 24.49 with a total of 18,008 shares traded.
Over the past week, the price has changed by +1.15%, over one month by -2.30%, over three months by +4.38% and over the past year by +5.15%.
Yes, based on ValueRay Fundamental Analyses, Unum (NYSE:UNMA) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 78.12 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UNMA as of May 2025 is 25.28. This means that UNMA is currently overvalued and has a potential downside of 3.23%.
Unum has no consensus analysts rating.
According to ValueRays Forecast Model, UNMA Unum will be worth about 27.3 in May 2026. The stock is currently trading at 24.49. This means that the stock has a potential upside of +11.51%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 27.3 | 11.5% |